NCT07885423
68Ga-XMFH01 PET/Fluorescence Imaging in Prostate Cancer
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 1 with changes below, 2 re-verified with no change.
- Study First Submitted
Endpoints
Primary
Diagnostic efficacy
Timeframe: 1 month
Secondary (2)
Concordance Between Intraoperative Fluorescence Imaging and Histopathology for Prostate Surgical Margin Assessment
Concordance Between Intraoperative Fluorescence Imaging and Histopathology for Pelvic Lymph Node Assessment
Arms and interventions
68Ga-XMFH01Experimental
Participants will undergo preoperative 68Ga-XMFH01 PET/CT imaging for tumor detection and localization, followed by intraoperative fluorescence-guided surgical navigation using the same dual-modality probe.
Diagnostic tests: 68Ga-XMFH01 PET/CT
Sites
1 site in 1 country
- The First Affiliated Hospital of Xiamen UniversityXiamen, Fujian, China